PATENT CLAIM ANALYSIS

Application Number: 16093376
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "342000"]

Abstract:
Disclosed is a compound for treating fibrosis-related diseases, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Claim (Index 4):
The compound, pharmaceutically acceptable salt and tautomer thereof of  claim 1 , wherein structural unit

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16325626', '16326976', '16066852', '16096848', '15750704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.818790838034332
- 35 USC 102 Novelty (BERT): 0.5602988894997063
- Combined Prediction Score: 0.7929416431808693
- Mean Citation Score: 391.3555060000001
- Max Citation Score: 429.8432
- Similarity Product: 392.0443870811464

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test